Kazam Joshua A 4
4 · Allogene Therapeutics, Inc. · Filed Jun 15, 2023
Insider Transaction Report
Form 4
Kazam Joshua A
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-13+116,120→ 116,120 totalExercise: $5.70Exp: 2033-06-13→ Common Stock (116,120 underlying)
Footnotes (1)
- [F1]Vesting in 12 equal monthly installments